Metropolis Healthcare Ltd Share Price Today - Metropolis Healthcare Ltd Stock Price Live NSE/BSE

Metropolis Healthcare Ltd

NSE: METROPOLIS BSE: 542650

₹441.10

(-3.26%)

Mon, 30 Mar 2026, 04:53 am

MTF 5xInvest in Metropolis Healthcare Ltd with 5x Leverage Buy with MTF

Market Cap91.09B

PE Ratio54.53

Dividend0.23

Health Services

Medical/Nursing Services

24.5K

Metropolis Healthcare Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
8936.86
Net Profit
145.51
P/B
6.12
Sector P/E
53.74
P/E
55.83
EV/EBITDA
25.51
Debt/Equity (Industry)
0.18
Interest Cover (Industry)
12.13
ROCE (Industry)
17.76
RONW (Industry)
14.92
ROE
11.99
ROCE
14.96
Debt/Equity
0.17
EPS (TTM)
8.44
Dividend Yield
0
Book Value
69.09
Interest Cover
8.99

Analysis

all

Pros

Dividends paid are well covered by earnings (3.2x coverage).
Dividends after 3 years are expected to be covered by earnings (1.8x coverage).
Metropolis Healthcare's earnings are expected to grow significantly at over 20% yearly.
Metropolis Healthcare's earnings growth is expected to exceed the India market average.
Metropolis Healthcare's earnings growth is expected to exceed the low risk savings rate of 7.2%.

Cons

Metropolis Healthcare only just started paying a dividend, it is too early to tell if payments are increasing.
It is too early to tell whether Metropolis Healthcare has stable dividend payments.
Metropolis Healthcare's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
Metropolis Healthcare's dividend is below the markets top 25% of dividend payers in India (3.08%).
Cash flow for Metropolis Healthcare is expected to increase but not above the 50% threshold in 2 years time.

Financials

Ratios

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	48.88	48.89	48.89	48.90	49.40
FII	11.69	12.52	12.83	15.29	16.73
DII	34.73	33.10	32.40	30.30	30.00
Public	4.71	5.49	5.88	5.52	3.87
Government	0	0	0	0	0

Technical Analysis

RSI

29.46

MACD

-10.68

50 DMA

467.43

200 DMA

484.88

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	584.73	533.48	504.72	482.23	453.47	430.98	379.73
Fibonacci	533.48	513.91	501.81	482.23	462.66	450.56	430.98
Camarilla	490.04	485.35	480.65	482.23	471.25	466.55	461.86

Pivots Level: Classic

+102.50

584.73

+51.25

533.48

+22.48

504.72

482.23

Pivot Point

LTP: 416

-28.77

453.47

-51.25

430.98

-102.50

379.73

Moving Average

SMAEMA

Period

Value

10-EMA
441.28
20-EMA
450.59
30-EMA
456.34
50-EMA
463.46
100-EMA
472.11
200-EMA
475.47

Announcement Date	Purpose	Action	Ex Date
11 Mar 2026	bonus	3:1 Bonus Issue of Equity Shares	20 Mar 2026
04 Feb 2026	board-meetings	Quarterly Results
04 Nov 2025	board-meetings	Quarterly Results, Interim Dividend
04 Nov 2025	dividend	₹4.00 Dividend /Share	11 Nov 2025
11 Oct 2025	dividend	Interim Dividend - Rs. - 4	11 Nov 2025
22 Jul 2025	agm
31 Jul 2024	agm
04 Nov 2023	dividend	₹4.00 Dividend /Share	17 Nov 2023
17 Oct 2023	dividend	Interim Dividend - Rs. - 4	17 Nov 2023
21 Jul 2023	agm

Metropolis Healthcare Ltd

Aster DM Healthcare Ltd

Max Healthcare Institute Ltd

Narayana Hrudayalaya Ltd

Fortis Healthcare Ltd

Apollo Hospitals Enterprise Ltd

Metropolis Healthcare Ltd About

Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services.

Industry

Healthcare

Founded

2000

Headquarters

CEO

Ameera Sushil Shah

Employees

Contact

Website

http://www.metropolisindia.com

investor.relations@metropolisindia.com

Phone

91-22-62582810

Location

250 D Udyog Bhavan, Worli, Mumbai, Maharashtra, 400030

Year	History
2017	Metropolis Healthcare acquired Sanjeevani Pathology Laboratory in Rajkot.
2018	Metropolis Healthcare executed a Public-Private partnership agreement with the National AIDS Control Organisation, Government of India. Metropolis Healthcare implemented the Scheme of Amalgamation 2018. Metropolis Healthcare incorporated a subsidiary in Tanzania. Metropolis Healthcare was awarded for 'Best in Health and Fitness' in the Digital Campaign Awards by LH Insights. Metropolis Healthcare was awarded for 'Excellence in Customer Service & Delivery' by Biotrains. Metropolis Healthcare received a special jury mention for 'Service Excellence (Diagnostic Centre)' by FICCI at the Healthcare Excellence Awards.
2020	Metropolis Healthcare won the India CSR award for the 'Too Shy To Ask' App. Metropolis Healthcare was awarded India Diagnostic Service Provider Company of the year 2020.
2021	Metropolis Healthcare completed the acquisition of Hitech Diagnostic Centre. Metropolis Healthcare's Board of Directors approved the acquisition of Dr. Ganesan's Hitech Diagnostic Centre.
2024	Metropolis Healthcare Limited completed the acquisition of Metropolis Foundation. Metropolis Healthcare Limited acquired a 100% stake in Core Diagnostics Private Limited.

Client Name	Order Side	QTY	Avg Price	Date
CORE DIAGNOSTICS (MAURITIUS) PRIVATE LIMITED	Sell	292457	1905.11	04 Dec 2025
GRAVITON RESEARCH CAPITAL LLP	Buy	259625	1690.38	21 Dec 2023
GRAVITON RESEARCH CAPITAL LLP	Sell	280825	1683.49	21 Dec 2023
GRANDEUR PEAK INTERNATIONAL STALWARTS FUND	Sell	399485	1509.95	20 Oct 2023
GRANDEUR PEAK GLOBAL TRUST GRANDEUR PEAK INTERNATIONAL STALWARTS FUND	Buy	399485	1509.95	20 Oct 2023
GRANDEUR PEAK EMERGING MARKETS OPPORTUNITIES FUND	Sell	275352	1509.95	20 Oct 2023
GRANDEUR PEAK GLOBL TRUST GP EMERGING MARKETS OPPORTUNITIES FUND	Buy	275352	1509.95	20 Oct 2023
DURU SUSHIL SHAH	Sell	425000	3142.72	16 Nov 2021
CA LOTUS INVESTMENTS	Sell	314106	1341	03 Jul 2020
CA LOTUS INVESTMENTS	Sell	314017	1341	03 Jul 2020

Metropolis Healthcare Ltd News

Metropolis Healthcare Allots 15.55 Crore Bonus Shares

Metropolis Healthcare completes 3:1 bonus share allotment on March 23, 2026, issuing 15,54,95,826 new equity shares with record date March 20, 2026. Paid-up share capital increases to INR 41,46,55,536.

23 Mar 2026

companies

Metropolis Healthcare schedules analyst meet on March 25

Metropolis Healthcare Limited has scheduled an analyst and institutional investor meeting with Kotak Securities on March 25, 2026, at 3:00 p.m. IST as per regulatory requirements.

20 Mar 2026

companies

Metropolis Healthcare Bonus Shares Approved by Shareholders

Metropolis Healthcare shareholders overwhelmingly approved bonus share issuance through postal ballot with 98.36% votes in favor. The e-voting process concluded on March 08, 2026 with 4,69,54,514 votes supporting the resolution.

09 Mar 2026

co actions results

Metropolis Healthcare Approves 3:1 Bonus Issue

Metropolis Healthcare has approved the issuance of bonus equity shares at a ratio of 3:1, providing shareholders with three additional shares for every share held.

04 Feb 2026

co actions results

Metropolis Healthcare Q3FY26 Earnings Call on Feb 5

Metropolis Healthcare announces earnings conference call scheduled for February 5, 2026 at 09:00 AM IST to discuss Q3FY26 financial results for quarter ended December 31, 2025, organized by ICICI Securities.

30 Jan 2026

co actions results

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800